|
April. 17, 2023 |
|
|
Sept. 11, 2024 |
|
|
jRCT1030230038 |
Tele-Cognitive behavior therapy for Night Owl: Pilot study (TeCNO study) |
|
Tele-Cognitive behavior therapy for Night Owl (TeCNO study) |
Oi Hitomi |
||
University of human environments |
||
9-12 Dogo-Himata, Matsuyama, Ehime 790-0825, Japan |
||
+81-89-926-7008 |
||
h-oi@uhe.ac.jp |
||
Oi Hitomi |
||
University of human environments |
||
9-12 Dogo-Himata, Matsuyama, Ehime 790-0825, Japan |
||
+81-89-926-7008 |
||
hitomi.oi@ncnp.go.jp |
Recruiting |
May. 01, 2023 |
||
| 12 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1. Meeting DSM-5 diagnosis criteria of circadian rhythm sleep-wake disorder sleep-phase regressive type |
||
1. Engaged in shift work with night shifts |
||
| 12age old over | ||
| No limit | ||
Circadian Rhythm Sleep-Wake Disorders |
||
Cognitive Behavioral Therapy for circadian Rhythm sleep-wake disorders involves video/booklet self-study and 4 sessions within the intervention period, each approximately 30 minutes of remote CBT-R intervention (weeks 0-3). Session 1 consists of sharing a video clip on sleep-wake rhythms followed by an interview to establish target behaviors. Session 2 involves adjusting the sleep schedule and sharing video clip of daytime activities followed by adjusting the sleep schedule. Session 3 includes video sharing of daytime activities followed by adjustments to sleep schedule. In Session 4, video clip about maintenance and relapse prevention is shared, and interviews are conducted in addition to the review of the previous sessions. The study subjects and their parents or other family members may be present if they wish to participate in the session. |
||
D020178 |
||
D015928 |
||
Sleep midpoint calculated from sleep indices obtained by the wearable device Fitbit |
||
1. Occurrence of adverse events |
||
| University of human environments |
| Ministry of education | |
| Not applicable |
| Ethics committee, National Center of Neurology and Psychiatry | |
| 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, Tokyo | |
+81-42-341-2711 |
|
| rinri-jimu@ncnp.go.jp | |
| Approval | |
Jan. 13, 2023 |
Yes |
|
If other research institutions or companies wish to make secondary use of the data from this clinical trials, they must obtain the approval of the principal investigator, prepare a new protocol, etc., and have it reviewed and approved by the Ethics Review Committee. For the secondary use of the data, written informed consent has been obtained from the subjects in this clinical trials. |
none |